ANANDA Scientific Announces FDA approval of the IND for the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)
Por um escritor misterioso
Descrição
ANANDA Scientific Inc., (a biotech pharma company) today announced approval by the U.S. Food and Drug Administration (FDA) of the Investigational New
MUSC Catalyst News, MUSC
PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment, Addiction Science & Clinical Practice
MJBizMagazine July 2022 by MJBiz Daily - Issuu
The Opioid Crisis and Recent Federal Policy Responses
Opioid Use Disorder Diagnosis and Management
ANANDA Scientific
IJMS, Free Full-Text
TESCREAL hallucinations: Psychedelic and AI hype as inequality engines in: Journal of Psychedelic StudiesOnline First
ANANDA Scientific
de
por adulto (o preço varia de acordo com o tamanho do grupo)